Cellular and Humoral Immune Responses Induced by an HLA Class I–restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer
暂无分享,去创建一个
T. Enomoto | S. Morita | N. Hosen | Y. Oji | A. Tsuboi | Y. Oka | H. Sugiyama | A. Kumanogoh | J. Nakata | S. Nishida | F. Fujiki | H. Nakajima | Y. Ueda | S. Morimoto | T. Shirakata | K. Yoshino | Y. Nakae | T. Kimura | Mizuki Kanegae | Alzaaqi Shouq | Satoshi Ohno